Zacks Investment Research on MSN
Can Atlas momentum sustain MDB's subscription growth trend in 2026?
MongoDB’s MDB Atlas platform sits at the core of the company’s growth strategy as enterprises accelerate cloud database adoption and begin deploying AI-powered applications at scale. As a fully ...
DataMasters has announced the availability of weekly new business mailing lists designed to support business-to-business ...
Billionaire investor Bill Ackman on Saturday proposed merging SpaceX with Pershing Square SPARC Holdings, a special purpose acquisition rights vehicle created by his firm, Pershing Square Capital ...
Placebo-adjusted mean weight loss of 11.3% (27.3 lbs) with 120 mg dose in the 36-week Phase 2b ACCESS study with a 10.4% adverse event-related treatment discontinuation Placebo-adjusted mean weight ...
SAN FRANCISCO, Dec. 08, 2025 (GLOBE NEWSWIRE) -- Structure Therapeutics Inc. (NASDAQ: GPCR), a clinical-stage global biopharmaceutical company developing novel oral small molecule therapeutics for ...
Placebo-adjusted mean weight loss of 11.3% (27.3 lbs) with 120 mg dose in the 36-week Phase 2b ACCESS study with a 10.4% adverse event-related treatment discontinuation Placebo-adjusted mean weight ...
SAN FRANCISCO, Dec. 07, 2025 (GLOBE NEWSWIRE) -- Structure Therapeutics Inc. (GPCR), a clinical-stage global biopharmaceutical company developing novel oral small molecule therapeutics for metabolic ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results